Respiratory Mucosal Immunity: Kinetics of Secretory Immunoglobulin A in Sputum and Throat Swabs From COVID-19 Patients and Vaccine Recipients

Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing

(2021) Adnan I Qureshi et al.   CLINICAL INFECTIOUS DISEASES

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

(2021) Victoria Jane Hall et al.   LANCET

SARS-CoV-2 Viremia is Associated with COVID-19 Severity and Predicts Clinical Outcomes

(2021) Jana L Jacobs et al.   CLINICAL INFECTIOUS DISEASES

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

(2021) Moriah Bergwerk et al.   NEW ENGLAND JOURNAL OF MEDICINE

Scent of a vaccine

(2021) Frances E. Lund et al.   SCIENCE

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models

(2021) Neeltje van Doremalen et al.   Science Translational Medicine

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

(2020)   Nature Microbiology

Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients

(2020) Hai-qiong Yu et al.   EUROPEAN RESPIRATORY JOURNAL

Long‐term coexistence of SARS‐CoV‐2 with antibody response in COVID‐19 patients

(2020) Bin Wang et al.   JOURNAL OF MEDICAL VIROLOGY

Antibody responses to SARS-CoV-2 in patients with COVID-19

(2020) Quan-Xin Long et al.   NATURE MEDICINE

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

(2020) Ahmed O. Hassan et al.   CELL

Characteristics of SARS-CoV-2 and COVID-19

(2020) Ben Hu et al.   NATURE REVIEWS MICROBIOLOGY

A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction

(2020) Monir Ejemel et al.   Nature Communications

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models

(2020) Min-Wen Ku et al.   Cell Host & Microbe

Evaluation of serum IgM and IgG antibodies in COVID‐19 patients by enzyme linked immunosorbent assay

(2020) Chang Zhou et al.   JOURNAL OF MEDICAL VIROLOGY

Enhanced SARS-CoV-2 neutralization by dimeric IgA

(2020) Zijun Wang et al.   Science Translational Medicine

IgA dominates the early neutralizing antibody response to SARS-CoV-2

(2020) Delphine Sterlin et al.   Science Translational Medicine

IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration

(2018) Yoshihiko Terauchi et al.   Human Vaccines & Immunotherapeutics

Secretory immunoglobulin A induces human lung fibroblasts to produce inflammatory cytokines and undergo activation

(2018) S. Arakawa et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Development of monoclonal antibodies against Sj29 and its possible application for schistosomiasis diagnosis

(2017) Cui-Ping Ren et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune Responses and Cross-protective Immunity Against Influenza Viruses

(2010) Lea Torrieri-Dramard et al.   MOLECULAR THERAPY